SC
OACC

Sculptor Capital’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Sculptor Capital’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.68M Hold
530,807
– – 0.05% 194
2026
Q1 		$5.62M Buy
530,807
+270
+0.1% +$2.87K 0.06% 170
2025
Q4 		$5.61M Buy
530,537
+30,537
+6% +$323K 0.06% 181
2025
Q3 		$5.25M Hold
500,000
– – 0.06% 184
2025
Q2 		$5.22M Buy
500,000
+250,000
+100% +$2.59M 0.07% 170
2025
Q1 		$2.56M Hold
250,000
– – 0.05% 168
2024
Q4 		$2.49M Buy
+250,000
New +$2.49M 0.03% 185

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Sculptor Capital's OACC Position: Q2 2026 in Review

Sculptor Capital held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q2 2026 at 530,807 shares worth $5.68M. The position accounts for 0.05% of the portfolio, ranked #194.

Sculptor Capital first reported a position in OACC in Q4 2024 and has held it in 7 quarters since. 50 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Sculptor Capital held 530,807 shares of Oaktree Acquisition Corp III Life Sciences worth $5.68M as of Q2 2026.
  • Sculptor Capital left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences made up 0.05% of Sculptor Capital's portfolio in Q2 2026, its #194 holding.
  • Sculptor Capital first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • 50 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Sculptor Capital's 13F filing for Q2 2026, filed 14 Aug 2026.